Close Search

IP Forum for Life Sciences

Hyatt Regency Huntington Beach Resort and Spa, CA

December 4–6, 2022


Intangible assets are the crown jewels of the world’s most valuable life sciences companies.

Today’s IP executives face seemingly limitless opportunities to leverage intangible assets, with a commensurate volume of threats. As a result, they must be as informed, nimble, and forward-thinking as any corporate leaders, for the success of their companies and the improvement of life across the globe.

Advisory Board:

  • Shilpi Banerjee (Nationwide Children’s Hospital), Deputy General Counsel, Intellectual Property
  • Mike Binns (Meta), Associate General Counsel, Intellectual Property
  • Bryan Boyle (Alkahest),  Vice President, Legal
  • Kerri Braun Deputy General Counsel, Intellectual Property Kids II
  • Scott Brown (Expro Group), Chief Intellectual Property Counsel
  • Susan Do (Pizza Hut Global Digital & Technology),  Legal Director, Intellectual Property
  • Vincent Duffy (Technicolor),  Chief Patent Counsel
  • J. Scott Evans (Adobe),  Director, IP & Advertising Law
  • Colin Heitzmann Senior Corporate Attorney, Legal Affairs Otsuka Pharmaceuticals
  • Russ Jacobs (Starbucks), Director, Managing Counsel, Intellectual Property
  • Crystal Lacey (SUEZ Water Technologies),  Executive Counsel, Intellectual Property
  • Ann LaFeir (USAA), Senior Intellectual Property Counsel
  • Sanjesh Sharma (Johnson & Johnson Surgical Vision), Assistant General Counsel, Patents
  • Beverly Shin (Beachbody), Group Vice President, Intellectual Property
  • Bruce Wu (Sestina Bio), Chief Legal Officer


Topics for discussion include:

  • Crafting & Implementing Your IP Game Plan
  • What the Patent Litigator Wishes the Patent Prosecutor Had Thought About
  • Do I Really Own That?
  • Fortifying the Vault: Strategies for Mitigating Trade Secret Theft
  • Patent Litigation: Essential Strategic and Practical Considerations to Align Litigation With Business Objectives
  • Patents in the Cross-Hairs of the Affordable Drug Conversation
  • IPRs: What Has Been Happening at the PTAB?
  • Preparation for and Management of IP Due Diligence in Life Science Transactions
  • Protecting Innovation Through Strong Peer Networks: How Can Chief IP Officers Help Their Company With the Growing Patent Troll Issue?
  • Enablement of Antibody and Other Biologic Product Patent Claims In View of the Supreme Court’s Recent Grant of Review
  • Weathering the Storm: In Search of a Safe-Harbor
  • Diversity & Inclusion: Bringing the Best Team to the Table
  • Partnering With Outside Counsel & Legal Service Providers To Manage Legal Costs
  • Enhancing Your Research & Development Pipeline
  • Collaborating With Academic Institutions To Drive Innovation

Please view Consero’s health and safety protocols for in-person events here.

View helpful transportation options here. 



Critical Voices, Exceptional Dialogue

Hear from and interact with some of the most influential voices in this space.

Daniel Attaway


Womble Bond Dickinson (US) LLP

Gwilym Attwell


Fish & Richardson P.C.

David Adamovich

Biotechnology Group Leader

Global Prior Art, Inc.

Ritesh Agrawal

Director of Intellectual Property

Pivot Bio

Brian Babcock

Founder, Technology & Intellectual Property Director


Jay Barron

Senior Director, Intellectual Property

Acer Therapeutics

Briana Barron

Vice President, Intellectual Property

Arcus Biosciences

Cristin Berkey

Senior Director of Intellectual Property and Contracts

Abata Therapeutics

Padmanabh Bhatt

Senior Vice President, Intellectual Property and Chief Scientific Officer

Supernus Pharmaceuticals, Inc.

Kate Bishop

Executive Director, Intellectual Property

Visus Therapeutics

Jeff Bolland

Intellectual Property Counsel

10x Genomics

Mary Bourke


Womble Bond Dickinson (US) LLP

Bryan Boyle

General Counsel


Shifali Chatrath

Senior IP Manager

Hummingbird Bioscience

Fangli Chen, Ph.D.

Partner, Vice-Chair of Life Sciences Patent Group

Proskauer Rose LLP

Elbert Chiang

Vice President, Head of Intellectual Property

Beam Therapeutics

Jay Clare

Associate Director, IP

Valo Health, Inc.

Catherine Coombes

Director, Patents


William Coppola

Vice President, Intellectual Property

Aerie Pharmaceuticals

John Covert


Sterne, Kessler, Goldstein & Fox P.L.L.C.

Joshua Davis


Womble Bond Dickinson (US) LLP

Corrin Drakulich


Fish & Richardson P.C.

Margaret Dunbar

Vice President, Intellectual Property


Philippe Edouard

Head Intellectual Property Counsel

Visterra, Inc.

Terrance Fitzgerald

Associate General Counsel, Head IP

Tolmar, Inc.

Wolfgang Flasche

Director and Head of IP, Intellectual Property

Immatics Biotechnologies GmbH

Aly Fuller

Vice President, Intellectual Property & Government Affairs

Prolacta Bioscience

Robert Ford

General Counsel, North America

Advanz Pharma

Eamonn Gardner



Troy Groetken


McAndrews, Held & Malloy, Ltd.

Leslie Grab

Vice President of Intellectual Property and Chief Privacy Officer


Siegmund Gutman

Partner, Chair of Life Sciences Patent Group

Proskauer Rose LLP

Pamela Guy

Senior Director, Intellectual Property


Aubrey Haddach

General Counsel, Corporate Secretary

RayzeBio, Inc.

Richard Hake

Chief IP Counsel

Metagenics, Inc.

David Holman Ph.D.


Sterne, Kessler, Goldstein & Fox P.L.L.C.

Wendy Hsu

Assistant General Counsel, Oncology SM


Sara Kerrane

Vice President, IP, Regulatory & Litigation Counsel

Glaukos Corporation

Philip Lee

Assistant General Counsel, Corporate Secretary

Alfred Mann Foundation for Scientific Research

Eric Lin

Senior Patent Counsel


Drew Lowery

Director of Life Sciences, Group Leader Biotechnology

Global Prior Art, Inc.

Eric Marandett

Co-Chair of IP Litigation

Choate, Hall & Stewart

Scott Miller

Deputy Chief Intellectual Property Counsel

Thermo Fisher Scientific

Kelly Morgan

Head of Intellectual Property & Legal

Arbor Biotechnologies

Jason Murata


Axinn, Veltrop & Harkrider LLP

Katherine Neville


Marshall, Gerstein & Borun

Christopher Potts

Associate General Counsel, Global Head of Intellectual Property

Legend Biotech

Paul Rivard

Vice President of Operations & General Counsel

MyMD Pharmaceuticals, Inc.

Lawrence Rozsnyai

Vice President, Intellectual Property, Licensing & Transactions

Olema Pharmaceuticals, Inc.

Sean Ryder

General Counsel

Genelux Corporation

Ken Seddon

Chief Executive Officer

LOT Network, Inc.

Sanjesh Sharma

Assistant General Counsel, Patents

Johnson & Johnson Surgical Vision, Inc.

Samuel Sherry

Senior Director, Intellectual Property Strategy

Thermo Fisher Scientific

Chuck Sholtz

Vice President, Intellectual Property

Nutcracker Therapeutics

Kyle Siegal

Chief Patent Counsel & Senior VP of Life Sciences

Skysong Innovations

Srividya Subramanian

Sr. Director, Legal and IP

Ikena Oncology, Inc.

Sanya Sukduang



Erik Spek

Vice President, Legal & Intellectual Property

Arrakis Therapeutics

Malaika Tyson, Ph.D.


McAndrews, Held & Malloy Ltd.

Daniel Yarbrough

Director, Intellectual Property

Element Biosciences

Rebecca Wais

Vice President, Intellectual Property & Legal Affairs

Tessera Therapeutics

Cristina Wittkopp

Associate Director, Intellectual Property

TwinStrand Biosciences

Ada Wong

VP of Intellectual Property

InterVenn Biosciences

Related Upcoming Events

From virtual activations to forums and roundtables at destinations across the country, Consero adapts to serve its attendees. Here’s what’s coming up within your field.

Request an Invitation